Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Development of a Metabolomic Test to Diagnose and Quantify Pancreatic Exocrine Insufficiency (The DETECTION Study)

NCT05980221 is registered in ClinicalTrials.gov with University Hospital Birmingham NHS Foundation Trust as lead sponsor.

NCT NCT05980221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05980221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Development of a Metabolomic Test to Diagnose and Quantify Pancreatic Exocrine Insufficiency (The DETECTION Study)
Lead sponsor
University Hospital Birmingham NHS Foundation Trust
Phase
Not applicable
Overall status
Unknown status
Start date
August 24, 2020
Completion date
October 31, 2024
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic exocrine insufficiency